< Back to search
Filter
1

Prostate Cancer Treatment Using Androgen Deprivation Therapy and Focal Prostate Ablation

for
Prostate Cancer
Location: Chicago IL
Sponsor: University of Chicago

Sex: Male

Age: 18+

Code: NCT05790213

Phase2, Recruiting

4-aminopyridine Treatment for Nerve Injury

for
Nerve Injury, Prostate Cancer
Location: Tucson AZ
Sponsor: John Elfar

Sex: Male

Age: 45 - 70+

Code: NCT03701581

Phase2, Phase3, Recruiting

Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy

for
Prostate Adenocarcinoma, Prostate Cancer,
Location: St Louis MO, San Francisco CA
Sponsor: David Oh

Sex: Male

Age: 18+

Code: NCT03821246

Phase2, Recruiting

Pembrolizumab With Androgen Deprivation Therapy and Radiotherapy for the Treatment of Patients With High Risk Localized Prostate Cancer

for
High Risk Prostate Carcinoma, Localized Prostate Adenocarcinoma,
Location: Portland OR
Sponsor: OHSU Knight Cancer Institute

Sex: Male

Age: 18+

Code: NCT06528210

Phase2, Recruiting

A Study of MT-4561 in Patients With Various Advanced Solid Tumors

for
Head and Neck Squamous Cell Carcinoma (HNSCC),
Location: Columbus OH, Grand Rapids MI, Houston TX,
Sponsor: Tanabe Pharma America, Inc.

Sex: All

Age: 18+

Code: NCT06943521

Phase1, Phase2, Recruiting

Interested in new prostate cancer trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

for
Castration Levels of Testosterone,
Location: Brewer ME, Bath ME, Portland ME, Scarborough ME,
Sponsor: SWOG Cancer Research Network

Sex: Male

Age: 18+

Code: NCT03678025

Phase3, Recruiting

A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors

for
Metastatic Castration-Resistant Prostate Cancer (mCRPC),
Location: Boston MA, Providence RI, New Haven CT, New York NY,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT03972657

Phase1, Phase2, Recruiting

Anti-inflammatory Drugs and Serum Prostate-Specific Antigen Test

for
Prostate Cancer, Prostate Inflammation, PSA
Location: Albany NY, Hershey PA, Chicago IL
Sponsor: Albany Medical College

Sex: Male

Age: 18 - 70+

Code: NCT05629494

Recruiting

Sustainable Implementation of the EXCEL Exercise Oncology Program Across Canada

for
Cancer, Prostate Cancers, Breast Cancers, Colon Cancer,
Location: Halifax, Montreal, Toronto, Calgary, Vancouver
Sponsor: University of Calgary

Sex: All

Age: 18+

Code: NCT06960291

Recruiting

Immunotherapy Study of Evofosfamide in Combination With Ipilimumab

for
Pancreatic Cancer, Melanoma,
Location: Houston TX
Sponsor: Threshold Pharmaceuticals

Sex: All

Age: 18+

Code: NCT03098160

Phase1, Recruiting

The Impact of Low Pressure Pneumo in RARP II

for
Prostate Cancer
Location: Wyoming MI
Sponsor: Metro Health, Michigan

Sex: Male

Age: 40+

Code: NCT04394676

Recruiting

Real Time MRI Fused to Cone Beam CT Guided Biopsies of the Prostate.

for
Prostate Cancer
Location: Kingston
Sponsor: Queen's University

Sex: Male

Age: 18+

Code: NCT04180592

Recruiting

MRI Screening in Men at High Risk of Developing Prostate Cancer

for
Prostate Cancer Screening
Location: Chicago IL, Glenview IL
Sponsor: University of Chicago

Sex: Male

Age: 18+

Code: NCT05608694

Recruiting

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

for
Bladder Adenocarcinoma, Bladder Clear Cell Adenocarcinoma,
Location: Peabody MA, Burlington MA, Commack NY, Uniondale NY,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT03866382

Phase2, Recruiting

Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial

for
Recurrent Castration-Sensitive Prostate Carcinoma,
Location: Jacksonville FL, Rochester MN, Phoenix AZ
Sponsor: Mayo Clinic

Sex: Male

Age: 18+

Code: NCT06378866

Phase2, Recruiting

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

for
Metastatic Castration-resistant Prostate Cancer (mCRPC),
Location: New Haven CT, Quebec, New Brunswick NJ, Montreal,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06136650

Phase3, Recruiting
New

Use of PuraStat Following Aquablation to Determine if There is Change in Hematuria & Probability of Same Day Discharge

for
BPH (Benign Prostatic Hyperplasia),
Location: Glenview IL
Sponsor: Endeavor Health

Sex: Male

Age: 18+

Code: NCT07789041

Recruiting

BPH Global Registry

for
Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms
Location: Montreal, Toronto, Los Angeles CA
Sponsor: Société Internationale d'Urologie

Sex: Male

Age: 18+

Code: NCT05543200

Recruiting

Enhanced Clinical Decisions for Management of Benign Prostatic Hyperplasia Using Patient-Reported Outcomes

for
Benign Prostatic Hyperplasia
Location: Glenview IL
Sponsor: Northwestern University

Sex: Male

Age: 50+

Code: NCT05898932

Recruiting

Prostate Artery Embolization: Single Center Experience

for
Benign Prostatic Hyperplasia (BPH),
Location: Jackson MS
Sponsor: University of Mississippi Medical Center

Sex: Male

Age: 45+

Code: NCT04766268

Recruiting